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Abstract
Background: As many other European healthcare systems the Danish healthcare system (DHS) has targeted
chronic condition care in its reform efforts. Benchmarking is a valuable tool to identify areas for improvement. Prior
work indicates that chronic care coordination is poor in the DHS, especially in comparison with care in Kaiser
Permanente (KP), an integrated delivery system based in the United States. We investigated population rates of
hospitalisation and readmission rates for ambulatory care sensitive, chronic medical conditions in the two systems.
Methods: Using a historical cohort study design, age and gender adjusted population rates of hospitalisations for
angina, heart failure, chronic obstructive pulmonary disease, and hypertension, plus rates of 30-day readmission
and mortality were investigated for all individuals aged 65+ in the DHS and KP.
Results: DHS had substantially higher rates of hospitalisations, readmissions, and mean lengths of stay per
hospitalisation, than KP had. For example, the adjusted angina hospitalisation rates in 2007 for the DHS and KP
respectively were 1.01/100 persons (95%CI: 0.98-1.03) vs. 0.11/100 persons (95%CI: 0.10-0.13/100 persons); 21.6% vs.
9.9% readmission within 30 days (OR = 2.53; 95% CI: 1.84-3.47); and mean length of stay was 2.52 vs. 1.80 hospital
days. Mortality up through 30 days post-discharge was not consistently different in the two systems.
Conclusions: There are substantial differences between the DHS and KP in the rates of preventable hospitalisations
and subsequent readmissions associated with chronic conditions, which suggest much opportunity for
improvement within the Danish healthcare system. Reductions in hospitalisations also could improve patient
welfare and free considerable resources for use towards preventing disease exacerbations. These conclusions may
also apply for similar public systems such as the US Medicare system, the NHS and other systems striving to
improve the integration of care for persons with chronic conditions.
Background
Healthcare systems are undergoing reform in many coun-
tries including England, the United States, and Denmark.
In all countries, there is interest in improving the quality
and efficiency of medical care, as well as heightened con-
cern about the continued growth in medical spending
both in absolute terms and relative to other sectors of the
economy, e.g., spending as a percentage of each nation’s
Gross Domestic Product. As more nations and systems
within each nation strive to improve care, there is need for
comparative information, at a minimum to provide bench-
marks and examples of what is possible [1-3].
Much attention has focused on hospital care, which is
particularly costly for both society and individual
patients. For patients with chronic medical conditions,
hospitalisations are easily measureable clinical events that
represent incident cases or exacerbations of the underly-
ing condition. Previous research also suggests that these
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care, thus the rates of hospitalisations or readmissions
when there is an initial hospitalisation, provide informa-
tion on medical quality, including on the level of care
coordination for patients with these complex conditions
[4-10]. High numbers of hospitalisations for ambulatory
care sensitive conditions (ACSCs) have been identified in
a number of European countries, as well as among sub-
populations in the United States with known problems
with care such as patients without healthcare insurance
or who receive care in highly fragmented systems [11-14].
Within recent years the US managed care organisation
Kaiser Permanente (KP) has started to influence the
mindsets and policy development within many European
healthcare systems [15]. KP has been highlighted as a
successful model of integrated and cost-effective care
and prior work has found that the Northern California
Region of KP had fewer hospital admissions for chronic
diseases compared to the National Health Service (NHS)
[16]. More recent research have indicated substantially
poorer care coordination during transitions from hospi-
tal to primary care providers in the Danish Healthcare
System (DHS), compared to KP [17].
We hypothesised that KP had lower rates of hospitali-
sation and readmissions given hospitalisation for preven-
table hospitalisations for chronic medical conditions
compared to the DHS. Our larger immediate objective
was to investigate the potential areas for chronic care
improvement in the DHS, including basic estimates of
excess hospitalisations within the Danish system relative
to the Kaiser benchmark.
Methods
Settings and population
The two settings have several substantial differences in the
organisation and reimbursement of care. In past studies,
KP has been highlighted as a successful model of inte-
grated care with a strong focus on prevention, primary
care facilities organised in highly specialised medical cen-
tres employing both primary care and speciality care phy-
sicians, and well developed, integrated health information
management systems [18,19]. In the DHS, outpatient care
entails self-employed general practitioners (GPs) serving
as “gatekeepers” to the healthcare system and specialists
working in private practice and at in ambulatory clinics
located within hospitals. While the DHS also has extensive
use of computer-based clinical systems, these systems are
typically not integrated, and clinical information is rarely
shared electronically between GPs and specialists or
hospitals.
KP operates in nine states and Washington DC and is
the largest not-for-profit managed care organization in
the US with 8.2 million members [20]. KP is a consor-
tium of three separate but interdependent groups of
entities: the Kaiser Foundation Health Plan and its regio-
nal operating organizations, Kaiser Foundation Hospital
and the Permanente Medical Groups. Kaiser Foundation
Health Plan and Hospitals are integrated with legal sepa-
rate physician group practices called Permanente Medical
Groups. The health plan is the insurance part of the
organisation, while the hospitals and medical group pro-
vide all clinical services. KP is financed from membership
premiums and co-payments pooled by Kaiser Foundation
and reallocated to the medical centres and tightly linked
multi-specialty physician group according to annual con-
tracts. All physicians in The Permanente Medical Group
(TPMG) are reimbursed by salary; Kaiser Foundation
hospitals operate under annual budgets. Within KP, com-
prehensive health services are provided including hospital
admission, sub-acute care, ambulatory and preventive
care, accident and emergency, optometry, rehabilitation,
and home healthcare [21]. A typical patient in need of
primary care, e.g. due to a chronic condition, will, in KP
be treated and cared for solely in an out-patient medical
centre. The medical centre will have all necessary outpa-
tient facilities available, including internal medicine phy-
sicians, geriatricians, specialists, nurse practitioners,
nurses, health educators, administrative personnel, a
pharmacy, and an emergency department. The physicians
have access to in-house laboratory facilities and other
advanced medical equipment. When necessary, patients
are admitted to a hospital, and subsequent care and some
rehabilitation will be administered outside the hospital at
a skilled nursing facility (SNIF). Information exchange
between providers is facilitated through the operational
electronic health record KP HealthConnect. This system
also allows for multiple patient panel management and
two way patient contact [22].
The DHS is funded mainly through taxation and belongs
to the same family of healthcare systems as those of the
other Scandinavian countries and the United Kingdom
[23,24]. The DHS covers all inhabitants. Danish health ser-
vices are delivered partly by small physician practices and
partly public hospitals. Specific public health services are
delivered by the municipalities. Physician practices include
both GP practices and specialist practices, the latter co-
providing out-patient services with the hospitals. They are
owned and run by the senior physicians according to con-
tracts with the Public Health Insurance. GP services are
financed by a mixture of fee for service (75%) and capita-
tion (25%) and specialist services entirely by fee for ser-
vices. Hospitals are reimbursed by a combination of
budgets and DRGs per admissions. Since 2004, 50% of the
hospitals income must be DRG value based. Prior to 2007
the health services were delivered by 14 counties headed
by elected politicians; public expenditure for the Public
Health Insurance, of the public hospitals and fees for
patients admitted to private hospitals is financed by
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grants. Since 2007 the same services are delivered by five
regions headed by elected politicians and the public
expenditure is financed by a demographically adjusted
national grant (80%) and municipality payments (20%)
[23].
A prior study comparing inputs and performance of KP
and the DHS shows that KP employs fewer physicians per
capita than the DHS and has a lower use of hospital beds
and lower acute care admission rates than the DHS. How-
ever, per capita expenditures are significantly higher for
KP than the DHS, in part because of salary differences for
clinical staff as well as differences in the numbers and
types of support staff. The same study showed that more
KP members reported having documented chronic medi-
cal conditions than did Danish citizens: 6.3% reported hav-
ing diabetes mellitus in KP vs. 2.8% in DHS; 19% reported
having hypertension in KP vs. 8.5% in DHS; and 1.0%
reported having a stroke in KP vs. 0.2% in DHS [25].
In this study, we focused on people aged 65 and over to
increase the comparability of the two populations. For
example, in the US, citizens aged 65 years and older are
eligible for publicly financed insurance coverage (Medi-
care) at levels comparable to the DHS. Other ongoing
work by our group suggests that the Kaiser Medicare
population also resembles the overall US Medicare popu-
lation, at least with respect to predicted Medicare
spending.
Measures, data sources, and data collection
We used the definition of ambulatory care sensitive con-
ditions (ACSCs) from the U.S. Agency for Healthcare
Research and Quality (AHRQ), which defines them as
admissions for diagnoses that could have been prevented
or ameliorated with currently recommended outpatient
care, according to recent evidence from population-based
studies [26]. The face validity, precision, minimum bias,
and construct validity have been described elsewhere
[27]. In this report, we focus on hospitalisations for
ACSCs for five selected chronic medical conditions:
angina (without procedures), chronic obstructive pul-
monary disease (COPD), congestive heart failure (CHF),
diabetes mellitus (DM), and hypertension (HTN). We
used the population sizes of individuals aged 65+, in each
system in each year, to calculate the rates of these clinical
events representing chronic condition exacerbations. In
other words, for both the DHS and KP, we divided the
numbers of subjects with each of the five types of clinical
events by the total number of subjects alive in January of
each year. To see how hospitalisation rates compared for
a non-preventable, non-elective admission in the two sys-
tems, we also examined rates of appendicitis, which
almost always requires a hospitalisation, are unlikely to
be related to quality of outpatient medical care, and
provides information on potential differences in access to
care [28].
We translated ICD-9 diagnosis codes used in the AHRQ
specifications of ACSCs to ICD-10 codes using the New
Zealand Health Information Service ICD-10/ICD-9 con-
verter http://www.nzhis.govt.nz/moh.nsf/pagesns/254.
Subsequently, two co-authors with clinical backgrounds
reviewed the codes to improve sensitivity and to ensure
that the ICD-10 codes covered the ICD-9 codes used in
the AHRQ definition (see additional file 1). Further, lead-
ing hospital specialists in the DHS were contacted in order
to validate that the ICD-10 codes covered the codes used
in practice. In keeping with the AHRQ definition, we
excluded transfers from other hospital departments
(except transfers from emergency departments, outpatient
clinics, and transfers from outside the KP system).
We obtained data for 2002 through 2007 on length of
stay, principal diagnosis, hospitalisation date, hospital and
department, and type of contact to the hospital (admis-
sion, outpatient visit, short-stay admission, or emergency
department visit). The Danish National Patient Registry
and KP’s administrative and clinical databases provided
information about emergency department visits, ambula-
tory visits, hospitalisations with principal diagnosis, age,
and gender.
We also examined deaths among these patients with
chronic conditions. While death arguably will be influ-
enced by both medical and non-medical factors including
genetic, lifestyle, and socio-economic conditions, com-
pared with hospitalisations, findings of lower hospitalisa-
tions combined with greater mortality would raise
concerns about underuse of medical care. Similarly, find-
ings of shorter lengths of stay combined with greater mor-
tality would raise concerns about premature hospital
discharge. We obtained mortality data from the Danish
Civil Registration System, and from KP’s administrative
and clinical databases. We obtained information about
population size from Statistic Denmark and KP’s adminis-
trative databases. The Kaiser Foundation Research Insti-
tute Institutional Review Board reviewed and approved the
study. Separate Danish ethics approval was not required.
Statistical analysis
We calculated annual ACSC hospitalisation rates for the
five selected conditions in 2002-2007. Using the popula-
tion sizes by age and gender in January of each year as
the denominator, we calculated age- and gender-specific
hospitalisation rates for each system in each year. We
used direct standardisation to find the annual age- and
gender- adjusted rates for each of the five conditions, tak-
ing differences in the structure of the two populations
into account by standardising the KP population to the
Danish population. The same analyses were repeated,
excluding one-day hospitalisations to investigate if they
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not the other. We used a logistic model to calculate the
odds of rehospitalisation within 30 days after discharge
for persons hospitalised with an ACSC for one of the five
selected conditions in each year. The models only include
patients discharged alive and adjusted for age, gender and
month of initial admission. We calculated length of stay
for all ACSC hospitalisations excluding in-patients deaths
for the five selected conditions, and the odds of death up
to 30 days after discharge. In sensitivity analyses, we
separately examined the odds of death during the hospi-
talisation, and the odds of death within 30 days of the
initial hospitalisation for an ACSC for one of the five
selected conditions, again using logistic models adjusted
for age, gender, length of stay, and year and month of
admission.
In order to estimate the approximate resources asso-
ciated with the higher rehospitalisation rates in the DHS,
we used Diagnosis Related Group (DRG) costs obtained
from the Danish National Patient Registry. This estimation
of the DHS costs if it had event rates equivalent to those
in KP provide an upper bound on the resources potentially
available for reallocation in the DHS.
Results
In 2002, there were 794,575 persons in the DHS and
374,290 persons in KP who were 65+ years of age; and in
2007, there were 834,741 and 399,270 persons in each sys-
tem respectively. During this period between 2002 and
2007, 159,322 in the DHS and 32,710 in KP were hospita-
l i s e da tl e a s to n c ef o re x a c e r b a t i o n so fo n eo ft h ef i v e
ambulatory care sensitive, chronic medical conditions.
Hospitalisation rates for chronic medical conditions
The hospitalisation rates in DHS decreased significantly
between 2002 and 2007: there was a 53% reduction in hos-
pitalisations for angina in DHS between 2002 and 2007;
38% reduction for COPD; 46% reduction for heart failure,
41% reduction for diabetes; and 13% reduction for
hypertension.
Despite the large DHS reductions over this six year per-
iod, the rates of hospitalisation remained significantly
higher in the DHS compared to KP (Table 1). For all five
conditions together, the 2007 age- and gender-standar-
dised hospitalisation rates were 2.5 times higher in the
DHS compared with KP: 5.21 hospitalisations/100 persons
(95%CI: 5.17-5.26) and 2.02 hospitalisations/100 persons
(95%CI: 1.98-2.06) in DHS and KP respectively. Across
conditions, the differences in hospitalisation rates ranged
from 9.2 times greater in DHS compared to KP for angina
to 1.1 times greater for CHF: for angina, the rate was 1.01
hospitalisations/100 persons in the DHS, 95%CI:0.98-1.03,
compared with 0.11 hospitalisations/100 persons in KP,
95%CI:0.10-0.13; and for CHF, the rate was 0.91
hospitalisations/100 persons 95%CI: 0.89-0.93, compared
with 0.85 hospitalisations/100 persons 95%CI: 0.82-0.88.
In sensitivity analyses that excluded one-day hospitali-
sations, the differences in hospitalisation rates between
DHS and KP for all five chronic conditions were similar
to the analyses using all hospitalisations. In contrast,
there was no statistically significant difference between
the hospitalisation rates for appendicitis in the DHS and
KP between 2002 and 2007 together. The rate was 0.07/
100 persons in the DHS, 95%CI: 0.06-0.07 compared
with 0.06/100 persons in KP, 95%CI: 0.06-0.07.
For all conditions, the mean length of stay was greater
in DHS compared with KP, though the mean decreased
significantly in DHS between 2002 and 2007 (for all five
conditions, the mean LOS was 4.63 days in 2002 and
4.08 days in 2007; in KP, the mean LOS was 3.94 days
in 2002 and 3.91 days in 2007.
Readmissions
In addition to the higher initial hospitalisation rates in
the DHS compared to KP, the percentage of patients hav-
ing a readmission also was higher in the DHS compared
to KP, e.g., 21.0% vs. 19.5% readmission (OR = 1.10 for
DHS vs. KP, 95%CI:1.03-1.16), for all five conditions in
2007 (Table 2). The largest difference in readmission
rates between the two systems was for readmissions after
an initial hospitalisation for angina, e.g., 23.0% vs. 12.4%
in 2002 (OR = 2.12, 95% CI: (1.64-2.74)) and 21.6% vs.
9.9% in 2007 (OR = 2.53, 95% CI:(1.84-3.47)) in the DHS
and KP respectively. In contrast, the odds of being read-
mitted within 30 days after a hospitalisation for diabetes
were significantly higher in KP than in the DHS. The
odds of being readmitted after being hospitalised with
COPD, hypertension, or CHF did not differ substantially
between the two systems for the majority of the study
period.
Mortality
Table 3 displays the percentage of hospitalisations
resulting in death either during the hospitalisation or up
to 30 days after discharge after a hospitalisation for each
of the five chronic medical conditions, as well as the
percent dying during the hospitalisation and after dis-
charge. The difference in mortality varied across the five
conditions, with statistically significant higher odds of
dying in DHS among patients admitted for heart failure
compared with KP, significantly lower odds of dying in
DHS compared with KP among patients admitted for
COPD, and no significant differences among the other
three conditions.
Discussion
The initial hospitalisation and mean length of stay for five
ambulatory care sensitive chronic medical conditions was
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system, compared with the Kaiser Permanente Integrated
Delivery System. Subsequent readmission rates also were
higher in the DHS for angina compared to the KP bench-
mark, but lower for diabetes compared to KP. The find-
ings on mortality were mixed. There was a higher
mortality in the DHS for patients with heart failure and
lower mortality for chronic obstructive pulmonary dis-
ease, but no statistically significant differences for the
other three conditions. In short, patients in the Danish
healthcare system appear more likely to require preventa-
ble hospitalisations associated with chronic medical con-
ditions, and have longer hospitalisations on average,
compared with patients in the KP system.
There are several strengths of the study, including the
quite large populations observed and the multi-year time-
frame; our adjustment of analyses for differences in popu-
lation characteristics and the timing of hospitalisations;
and our inclusion of a condition that is not sensitive to
ambulatory care as a control. Other strengths include the
focus on two health systems with excellent capture of hos-
pital data within electronic databases.
Comparing clinical outcomes across systems, however,
is challenging, even for relatively straightforward hospital
events and survival. We used hospitalization rates for
selected ACSC as an indicator for the quality of primary
care to patients with chronic conditions. However, there
are a number of potential alternative explanations for dif-
ferences in hospitalisation rates between the two systems.
These include unmeasured differences in health and cul-
ture of the populations of the two healthcare systems, the
level and quality of data capture, variations in access to
primary care due to formal and informal barriers, and
practice patterns within each system. In several cases, we
would expect a bias towards finding no differences in our
outcomes; in other cases, the effects are difficult to
Table 1 Hospitalisation rates per 100 persons aged 65 and over and mean length of stay (LOS)*
DHS KP
Rate (95% CI) LOS (SD) Rate (95% CI) LOS (SD)
Angina 2002 2.14 (2.11 - 2.17) 2.60 (3.4) 0.15 (0.14 - 0.17) 2.37 (2.0)
2003 1.96 (1.93 - 1.99) 2.46 (3.4) 0.13 (0.11 - 0.14) 2.07 (1.6)
2004 1.38 (1.35 - 1.40) 2.45 (3.1) 0.12 (0.11 - 0.13) 1.92 (1.5)
2005 1.30 (1.28 - 1.33) 2.31 (3.0) 0.11 (0.10 - 0.12) 1.83 (1.3)
2006 1.16 (1.14 - 1.19) 2.54 (3.1) 0.11 (0.10 - 0.12) 1.85 (1.3)
2007 1.01 (0.98 - 1.03) 2.52 (3.3) 0.11 (0.10 - 0.13) 1.80 (1.3)
COPD 2002 3.02 (2.98 - 3.06) 4.74 (6.3) 0.73 (0.70 - 0.76) 4.15 (5.2)
2003 2.88 (2.84 - 2.92) 4.42 (5.7) 0.68 (0.65 - 0.71) 4.19 (4.8)
2004 2.19 (2.16 - 2.22) 4.35 (5.7) 0.61 (0.58 - 0.63) 3.77 (4.2)
2005 2.10 (2.06 - 2.13) 4.36 (6.8) 0.58 (0.55 - 0.60) 3.69 (3.9)
2006 2.07 (2.04 - 2.10) 4.18 (6.0) 0.53 (0.50 - 0.55) 3.94 (3.9)
2007 1.86 (1.84 - 1.89) 3.98 (5.8) 0.50 (0.48 - 0.52) 4.03 (6.6)
CHF 2002 1.70 (1.68 - 1.73) 6.02 (8.1) 1.45 (1.41 - 1.49) 3.95 (4.0)
2003 1.65 (1.62 - 1.68) 5.94 (14.8) 1.16 (1.12 - 1.19) 3.84 (3.8)
2004 1.11 (1.09 - 1.13) 6.16 (6.9) 1.19 (1.16 - 1.23) 3.87 (4.2)
2005 1.00 (0.98 - 1.02) 5.94 (6.7) 1.09 (1.06 - 1.13) 4.05 (4.7)
2006 0.97 (0.95 - 0.99) 6.12 (7.1) 0.93 (0.90 - 0.96) 4.45 (5.2)
2007 0.91 (0.89 - 0.93) 5.68 (5.9) 0.85 (0.82 - 0.88) 4.27 (4.2)
Diabetes 2002 1.28 (1.26 - 1.31) 6.84 (12.9) 0.34 (0.32 - 0.36) 4.43 (6.6)
2003 1.38 (1.35 - 1.40) 7.08 (13.6) 0.37 (0.35 - 0.39) 4.40 (7.1)
2004 0.98 (0.96 - 1.00) 7.05 (9.1) 0.41 (0.39 - 0.43) 4.04 (5.1)
2005 0.90 (0.88 - 0.93) 6.14 (8.4) 0.46 (0.44 - 0.48) 4.60 (7.0)
2006 0.97 (0.95 - 0.99) 6.22 (6.8) 0.45 (0.43 - 0.47) 4.20 (6.0)
2007 0.75 (0.73 - 0.77) 5.62 (6.8) 0.48 (0.46 - 0.49) 3.96 (6.2)
Hypertension 2002 0.80 (0.78 - 0.82) 3.56 (8.2) 0.06 (0.05 - 0.06) 2.18 (1.9)
2003 0.88 (0.86 - 0.90) 3.68 (5.4) 0.06 (0.05 - 0.07) 2.09 (2.1)
2004 0.69 (0.67 - 0.71) 3.50 (6.7) 0.07 (0.06 - 0.08) 2.15 (2.6)
2005 0.66 (0.63 - 0.67) 3.33 (5.1) 0.06 (0.05 - 0.07) 1.98 (1.8)
2006 0.72 (0.70 - 0.74) 3.22 (4.3) 0.08 (0.07 - 0.08) 2.03 (1.8)
2007 0.70 (0.68 - 0.71) 3.04 (3.6) 0.08 (0.07 - 0.09) 2.38 (2.9)
*Age and gender adjusted hospitalisation rates and Mean Length of Stay (LOS) for all hospitalisations with the given diagnosis excluding inpatients deaths
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a
2002 2003 2004 2005 2006 2007
DHS
%
KP
%
OR
(95% CI)
DHS
%
KP
%
OR
(95% CI)
DHS
%
KP
%
OR
(95% CI)
DHS
%
KP
%
OR
(95% CI)
DHS
%
KP
%
OR
(95% CI)
DHS
%
KP
%
OR
(95% CI)
Angina 23.0 12.4 2.12
(1.64-2.74)
22.9 13.6 1.88
(1.45-2.44)
22.8 9.3 2.87
(2.07-3.86)
25.1 10.6 2.82
(2.07-3.86)
23.0 10.1 2.67
(1.94-3.67)
21.6 9.9 2.53
(1.84-3.47)
COPD 24.2 20.1 1.27
(1.15-1.41)
24.1 19.4 1.32
(1.19-1.46)
24.1 20.4 1.25
(1.12-1.39)
23.9 20.3 1.23
(1.10-1.38)
22.6 20.7 1.12
(1.00-1.26)
23.2 21.4 1.11
(0.99-1.25)
CHF 24.0 21.7 1.14
(1.05-1.24)
23.7 21.3 1.15
(1.05-1.25)
23.4 22.2 1.07
(0.98-1.18)
24.4 23.3 1.06
(0.97-1.16)
23.0 23.0 0.99
(0.90-1.10)
24.1 21.4 1.17
(1.05-1.29)
Diabetes 18.0 20.1 0.87
(0.75-1.02)
16.4 20.6 0.75
(0.66-0.86)
15.3 21.2 0.67
(0.59-0.77)
16.5 22.0 0.70
(0.61-0.79)
14.3 21.3 0.62
(0.54-0.70)
16.1 18.4 0.85
(0.74-0.98)
Hypertension 16.4 14.2 1.18
(0.79-1.78)
17.1 9.2 2.04
(1.30-3.22)
15.7 10.0 1.68
(1.12-2.52)
16.9 13.4 1.32
(0.89-1.94)
15.8 11.7 1.41
(0.98-2.03)
15.3 13.4 1.17
(0.84-1.64)
a Adjusted for age, gender, and month of initial hospitalisation
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0predict. The main threat to the findings is potential dif-
ferent use of hospitals for equal diagnoses in the two
systems.
Unmeasured differences in the clinical and socio-
demographic characteristics between the two populations
almost certainly contribute to some of the observed find-
ings. The DHS sample consists of the entire Danish
population aged 65 and older whereas the KP population
is a non-random sample of the US population that is
enrolled within a single health plan. Our ongoing work,
however, suggests that the KP population closely resem-
bles the US population aged 65+ with respect to pre-
dicted risk. The US population in general also may have
larger range in income levels compared to the Danish
population where the progressive taxation policy means
that few are very rich and few are very poor. Unmeasured
differences in the available public and private social ser-
vices also could contribute to some of the observed find-
ings. Public transportation, public food services and
o t h e rp u b l i cf u n d e ds e r v i c e sa r ea v a i l a b l ei nD e n m a r k
whereas such services are private in the US. More public
services available could favor lower readmissions in the
DHS compared to KP. However, it is difficult to predict
how differences in clinical and socio-demographic popu-
lation characteristics overall affect the outcomes because
of counterbalancing forces.
There are a number of social contextual issues that
could influence the results and for which there is an exten-
sive literature. Factors associated with genes, cultural
norms around diet and exercise, and individual behavior
such as smoking all could contribute to population level
differences in disease prevalence, disease severity, and
numbers and types of co-morbid diseases. The direction
of such factors, however, is difficult to predict. For exam-
ple, prior studies showed that Danes tend to both exercise
and smoke more that the KP population and the KP
population has higher self-reported prevalence of chronic
conditions than the Danish population [25].
Differences in data capture among the systems may also
to some degree contribute to some of the differences
between the healthcare systems. Diagnoses may be
recorded differently between the systems, which would
affect our findings. The intensity of diagnosis might also
differ, though the direction of the net effect is unclear with
more hospital use in the DHS resulting in greater opportu-
nity for hospital related diagnoses, but potentially higher
outpatient diagnostic intensity in the United States [29].
Another potential explanation for the differences in hos-
pitalization rates between the two systems is different use
of hospitals. Danish hospitals have a high number of beds
available compared to hospitals in KP, and supply is a
powerful determinant of utilisation, which also could
lower admission thresholds [25,30]. Correspondingly, the
two systems could have different thresholds for admission
to- and discharge from the hospital. Differences in admis-
sion thresholds alone, however, should result in lower
deaths in the system with more initial hospitalisations.
Higher hospitalisation rates combined with lower death
rates in a healthcare system might suggest potential ineffi-
ciency either because of unnecessary hospitalisations or
hospitalisations preventable with earlier intervention in
the outpatient setting. Higher hospitalisation rates com-
bined with higher death rates in a healthcare system, how-
ever, might suggest more serious quality problems.
Subsequent readmission rates were higher in the Dan-
ish healthcare system for angina compared to the KP
benchmark, whereas the readmission rates for diabetes
were lower in the DHS compared to KP. There is
amount of literature stating that readmission rates may
not serve as a valid indicator for quality of care. E.g. a
report by Williams and Fitton state that readmission,
perhaps on several occasions, may be generally preferred
Table 3 Percentage of ACSC hospitalisations ending in death during and within 30 days of discharge
a
All deaths during and within 30 days of
hospitalisation
Deaths during initial
hospitalization
Deaths within 30 days of
discharge
DHS
%
KP
%
OR
(95% CI)
DHS
%
KP
%
OR
(95% CI)
DHS
%
KP
%
OR
(95% CI)
Angina 2.3 1.8 1.27
(0.96-1.68)
0.4 0.2 1.77
(0.83-3.75)
1.9 1.6 1.19
(0.88-1.61)
COPD 8.5 10.5 0.79
(0.74-0.83)
2.6 2.8 0.94
(0.85-1.04)
5.9 7.7 0.74
(0.69-0.79)
CHF 18.0 13.1 1.47
(1.40-1.53)
8.6 3.6 2.51
(2.34-2.70)
9.5 9.5 1.00
(0.95-1.05)
Diabetes 5.8 5.9 0.97
(0.89-1.07)
2.1 1.3 1.60
(1.33-1.92)
3.7 4.6 0.79
(0.71-0.88)
Hypertension 1.3 1.1 1.20
(0.76-1.89)
0.5 0.2 2.05
(0.76-5.54)
0.9 0.9 0.99
(0.59-1.64)
OR = Odds ratio
aAdjusted for age, gender and year and month of admission
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Page 7 of 10to permanent admission, both by the patient and by the
system [31] and other studies have identified associa-
tions between readmissions and underlying physical
conditions [32,33]. We were not able to adjust the ana-
lyses for underlying chronic conditions as the data did
not include enough secondary diagnoses to do proper
case-mix adjustment. Consequently, differences in read-
mission rates between the systems may not be a good
indicator of quality differences among the systems.
Factoring in all of these issues, we believe that our
results are consistent with other studies suggesting pro-
blems in the quality of chronic disease care within the
DHS. This prior work includes findings of a more compre-
hensive and systematic approach to disease detection and
disease prevention in KP compared to the DHS. KP pro-
vides more medical (secondary and tertiary) prevention to
its members and more self-management support is pro-
vided in KP compared to the DHS. Additionally, disease
treatment and complication prevention within the health-
care systems will affect hospitalisation rates. The KP sys-
tem has structured chronic care management programmes
that integrate multiple elements, such as clinical guide-
lines, disease registries, proactive outreach, reminders,
multidisciplinary care teams, and performance feedback to
providers [34]. Also, KP’s integrated IT system, the medi-
cal centers in KP housing GPs and specialists as well as
aligned financial and non-financial incentives throughout
the system in KP make the interactions between providers
easier, leading to better coordination and more follow-up
which we believe result in lower initial hospitalisation
rates and lower readmission rates.
Programmes to improve chronic care management
have only recently been introduced in the DHS and are
still in the implementation phase and were not wide-
spread when the data from this study was obtained.
Additionally, the DHS is a more fragmented system with
general practitioners, hospitals, and preventive and reha-
bilitation services being paid from different public sec-
tors, without aligned incentives or a proactive approach
to prevention. Thus, prior studies conducted in the DHS
have indicated that lack of acute services in the munici-
palities responsible for home nursing care and nursing
homes to some extent caused undesirable hospitalisations
[35]. Further, prior studies conducted in the DHS suggest
a substantial amount of mistrust and lack of cooperation
between physicians in the different settings in the DHS
[36-38]. In addition to these clashing cultures, there also
is a pervasive lack of information integration across set-
tings and clinicians within the DHS. Accordingly, pre-
vious studies show that the coordination of care between
GPs, hospitals, and municipalities has been insufficient
[36,39]. Comparing hospitalisations for ACSCs within
healthcare systems can serve as a surveillance mechanism
to identify problems, but are not very precise in terms of
identifying how to target the cause of that problem. How-
ever, together, these findings combined with previous
studies on care coordination differences between DHS
and KP [17], and on quality improvements within the KP
system [34,40], suggest substantial opportunities to
improve the quality and efficiency of care in Denmark for
patients with chronic medical conditions, compared to
the KP benchmark. In addition to providing a benchmark
for potential quality improvement, the findings also sug-
gest room for efficiency gains. Over the six year period
from 2002 to 2007, the hospitalisation rates did decrease
within DHS, but on average remained several fold greater
in magnitude than the rates in KP, thus suggesting an
upper bound for improvement. In other words, in 2007
alone, among the 32,001 persons hospitalised in Den-
mark for a preventable hospitalisation, 19,300 (60%) of
them would not have been hospitalised, had the DHS
rates been comparable to those in KP; there were 26,662
excess hospitalisations (i.e., 61% of the 43,521 observed
hospitalisations in DHS in 2007 would not have occurred
if the DHS rate was equal to that of KP’s), and 5,599
excess readmissions (i.e., 61% of the 9,139 observed read-
missions in DHS in 2007). Reallocating these resources
from the hospital to preventing disease exacerbations in
the outpatient setting could yield welfare gains for
patients and their families, without requiring substantial
new investments.
While additional research using individual level data
on patient characteristics would improve the estimates
of rates within each system, these longitudinal estimates
within each system provide useful benchmarking infor-
mation that can guide future reform efforts in the DHS
as well as track the effects of any new reforms. Based on
our results obvious areas for future reform efforts in the
DHS may be improving the integration of services,
improving structured care to persons with chronic con-
ditions. However, it is critical to assess whether
approaches from one healthcare system can be directly
transferred to another system and whether major or
minor changes should take place to obtain the desired
effects [41]. Prior studies of implementation of technolo-
gies have shown that a technology, policy or function
can be transformed in a new context and that the new
context will influence how this approach is implemented
and how it works [42]. Thus, caution must be exercised
before transferring ideas or approaches used in KP to
the Danish healthcare setting. Fireman et al. investigated
savings resulting from the use of chronic care manage-
ment programmes in KP. Actual cost savings were elu-
sive, but programs could have sizable potential savings
[34]. The study only focused on healthcare costs and
savings. There is insufficient evidence that this approach
will achieve the same improvements in the DHS; how-
ever it can be hypothesized that investing in efforts to
Schiøtz et al. BMC Health Services Research 2011, 11:347
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Page 8 of 10improve the quality of chronic care by strengthening
outpatient care settings in the DHS will lead to fewer
preventable hospitalisations. Implementation of chronic
care management programs in the DHS cannot be
expected to create immediate savings in the healthcare
budget, but the potential for improved quality of care
and long term savings at the society level seems to be
substantial.
External benchmarking can be a valuable tool for health-
care system reforms striving to improve performance as it
can shed light on areas with potential for improvements
and provide inspiration for how to reform organisation
and delivery systems. As an example the study published
by Feachem et al. in 2002 comparing cost and perfor-
mance in Kaiser Permanente and the NHS was followed
up by additional studies and played an important role in
the decision about implementing chronic disease manage-
ment approaches in the NHS [43].
Conclusion
There are substantial differences between the DHS and
KP in the rates of preventable hospitalisations, mean
length of stay and readmission rates for ambulatory care
sensitive, chronic medical conditions. These empirical
benchmarking data suggest potential opportunities for
improvements in chronic care quality and efficiency
within the Danish healthcare system. Reductions in hos-
pitalisations also could improve patient welfare and free
considerable resources for use towards preventing dis-
ease exacerbations. However, the results of this study
confirm, that the details of care organization and coordi-
nation between service providers including rehabilitation
facilities and nursing homes are very important and
coordination does not happen automatically even within
very well established national healthcare systems like the
DHS. These conclusions may therefore also apply for
other healthcare systems like the NHS in the UK and
the US Medicare system striving to improve the integra-
tion of care for persons with chronic conditions.
Additional material
Additional file 1: Ambulatory care sensitive conditions - ICD-9 and
ICD-10 codes. A list of the ICD-9-codes for ambulatory care sensitive
conditions defined by the U.S. Agency for Healthcare Research and
Quality and the used ICD-10 codes for the five selected conditions:
angina (without procedures), chronic obstructive pulmonary disease
(COPD), congestive heart failure (CHF), diabetes mellitus (DM), and
hypertension (HTN).
Acknowledgements
Jennifer Green provided English text revision and correction. We thank the
Rockwool Foundation and the Agency for Healthcare Research and Quality
who funded this study.
Author details
1Steno Health Promotion Center, Steno Diabetes Center, Niels Steensensvej
8, DK-2820 Gentofte, Denmark.
2Section for Health Services Research,
Department of Public Health, Faculty of Health Science, University of
Copenhagen, Øster Farimagsgade 5, Building 10, DK-1014 Copenhagen K,
Denmark.
3Division of Research, Kaiser Permanente Medical Care Program,
2000 Broadway, Oakland, CA 94612, USA.
4Mongan Institute for Health
Policy, Massachusetts General Hospital and Partners Health Care System, 50
Staniford Street, 9
thFloor, Boston, MA, 02114; Department of Health Care
Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA, 02115, USA.
5Copenhagen Hospital Cooperation, Bispebjerg Bakke 23, Bispebjerg Hospital;
DK-2400 Copenhagen NV, Denmark.
6Danish Institute for Health Services
Research, Dampfærgevej 27-29, DK-2100 Copenhagen Ø, Denmark.
7Department of General Practice, University of Aarhus, Bartholins Allé 2, DK-
8000 Aarhus, Denmark.
8Kaiser Permanente Institute for Health Policy, One
Kaiser Plaza, 22
nd Floor, Oakland CA 94612 USA.
Authors’ contributions
MS designed the concept and conducts of the study, obtained, analysed
and interpreted data, and drafted the manuscript. MP obtained, analysed,
and interpreted data and commented on the manuscript. AF, JK and JH
assisted in study design, data analysis, and data interpretation, and provided
critical revision of the manuscript for important intellectual concepts. JS, AK,
MR and FD assisted in study design and in interpreting the data and
commented on the manuscript. All authors have approved the final
submitted manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 20 April 2011 Accepted: 22 December 2011
Published: 22 December 2011
References
1. Sox HC: Learning from the health care systems of other countries. Ann
Intern Med 2008, 148:78-79.
2. Public Policy Commitee of the American College of Physicians, Ginsburg JA,
Doherty RB, Raiston JF Jr, Senkeeto N, Cooke M, et al: Achieving a high-
performance health care system with universal access: what the United
States can learn from other countries. Ann Intern Med 2008, 148:55-75.
3. Schoen C, Osborn R, Doty MM, Bishop M, Peugh J, Murukutla N: Toward
higher-performance health systems: adults’ health care experiences in
seven countries, 2007. Health Affairs 2007, 26:w717-34.
4. Billings J, Zeitel L, Lukomnik J, Carey TS, Blank AE, Newman L: Impact of
socioeconomic status on hospital use in New York City. Health Affairs
1993, 12:162-173.
5. Bindman AB, Grumbach K, Osmond D, Komaromy M, Vranizan K, Lurie N,
et al: Preventable hospitalizations and access to health care. JAMA 1995,
274:305-311.
6. Bindman AB, Chattopadhyay A, Osmond DH, Huen W, Bacchetti P: The
impact of Medicaid managed care on hospitalizations for ambulatory
care sensitive conditions. Health Serv Res 2005, 40:19-38.
7. Epstein AM: Revisiting readmissions–changing the incentives for shared
accountability. N Engl J Med 2009, 360:1457-1459.
8. Jencks SF, Williams MV, Coleman EA: Rehospitalizations among patients in
the Medicare fee-for-service program. N Engl J Med 2009, 360:1418-1428.
9. Peikes D, Chen A, Schore J, Brown R: Effects of care coordination on
hospitalization, quality of care, and health care expenditures among
Medicare beneficiaries: 15 randomized trials. JAMA 2009, 301:603-618.
10. Sharma G, Fletcher KE, Zhang D, Kuo YF, Freeman JL, Goodwin JS:
Continuity of outpatient and inpatient care by primary care physicians
for hospitalized older adults. JAMA 2009, 301:1671-1680.
11. Caminal HJ, Starfield B, Sanchez RE, Hermosilla PE, Martin MM: [Primary
health care and hospitalizations in ambulatory care sensitive conditions
in Catalonia]. Rev Clin Esp 2001, 201:501-507.
12. Dr Foster Intelligence: Keeping people out of hospital London: Dr Foster;
2006.
13. Rizza P, Bianco A, Pavia M, Angelillo IF: Preventable hospitalization and
access to primary health care in an area of Southern Italy. BMC Health
Serv Res 2007, 7:134.
Schiøtz et al. BMC Health Services Research 2011, 11:347
http://www.biomedcentral.com/1472-6963/11/347
Page 9 of 1014. Saxena S, George J, Barber J, Fitzpatrick J, Majeed A: Association of
population and practice factors with potentially avoidable admission
rates for chronic diseases in London: cross sectional analysis. J R Soc
Med 2006, 99:81-89.
15. Strandberg-Larsen M, Schiøtz M, Frølich A: Kaiser Permanente revisited -
can European health care systems learn? Eurohealth 2007, 14:24-26.
16. Ham C, York N, Sutch S, Shaw R: Hospital bed utilisation in the NHS,
Kaiser Permanente, and the US Medicare programme: analysis of routine
data. British Medical Journal 2003, 327:1257.
17. Strandberg-Larsen M, Schiotz ML, Silver JD, Frølich A, Andersen JS, Graetz I,
et al: Is the Kaiser Permanente model superior in terms of clinical
integration?: a comparative study of Kaiser Permanente, Northern
California and the Danish Healthcare System. BMC Health Services
Research 2010, 10:91.
18. Feachem RG, Sekhri NK, White KL: Getting more for their dollar: a
comparison of the NHS with California’s Kaiser Permanente. BMJ 2002,
324:135-141.
19. Light D, Dixon M: Making the NHS more like Kaiser Permanente. British
Medical Journal 2004, 328:763-765.
20. Strandberg-Larsen M, Schiøtz ML, Frølich A: Kaiser Permanente revisited -
can european health care systems learn? Eurohealth 2007, 13:24-26.
21. Feachem RG, Sekhri NK, White KL: Getting more for their dollar: a
comparison of the NHS with California’s Kaiser Permanente. British
Medical Journal 2002, 324:135-141.
22. Scott JT, Rundall TG, Vogt TM, Hsu J: Kaiser Permanente’s experience of
implementing an electronic medical record: a qualitative study. British
Medical Journal 2005, 331:1313-1316.
23. Strandberg-Larsen M, Nielsen M, Vallgårda S, Krasnik A, Vrangbaek K,
Mossialos E: Denmark: Health system review. Health Systems in Transition
2007, 9(6).
24. van der Zee J, Kroneman MW: Bismarck or Beveridge: a beauty contest
between dinosaurs. BMC Health Serv Res 2007, 7:94.
25. Frølich A, Schiøtz ML, Strandberg-Larsen M, Hsu J, Krasnik A, Diderichsen F,
et al: A retrospective Analysis of Health Systems in Denmark and Kaiser
Permanente. BMC Health Services Research 2008, 8:252.
26. AHRQ: Quality Indicators - Guide to Prevention Indicators: Hospital Admission
for Ambulatory Care Sensitive Conditions AHRQ Pub.No. 02-RO203. Rockville,
MD: Agency for Healthcare Research and Quality; 2001.
27. UCSF-Stanford Evidence-based Practice Center: Refinement of the HCUP
Quality Indicators Rockville, MD; 2001.
28. Braveman P, Schaaf VM, Egerter S, Bennett T, Schecter W: Insurance-related
differences in the risk of ruptured appendix. N Engl J Med 1994,
331:444-449.
29. Song Y, Skinner J, Bynum J, Sutherland J, Wennberg JE, Fisher ES: Regional
variations in diagnostic practices. N Engl J Med 2010, 363:45-53.
30. Fisher ES, Wennberg JE, Stukel TA, Skinner JS, Sharp SM, Freeman JL, et al:
Associations among hospital capacity, utilization, and mortality of US
Medicare beneficiaries, controlling for sociodemographic factors. Health
Serv Res 2000, 34:1351-1362.
31. Williams EI, Fitton F: Factors affecting early unplanned readmission of
elderly patients to hospital. BMJ 1988, 297:784-787.
32. Leng GC, Walsh D, Fowkes FGR, Swainson CP: Is the emergency
readmission rate a valid outcome indicator? Quality in Health Care 1999,
8:234-238.
33. Victor CR, Vetter NJ: The early readmission of the elderly to hospital. Age
Ageing 1985, 14:37-42.
34. Fireman B, Bartlett J, Selby J: Can disease management reduce health
care costs by improving quality? Health Affairs (Millwood) 2004, 23:63-75.
35. Vinge S, Buch MS: Uhensigstmæssige indlæggelser - muligheder og
perspektiver for kommunerne [in Danish Undesirable hospitalisations -
posibilities and perspectives for the municipalities] Copenhagen: FOKUS DSI;
2007.
36. Seemann J, Antoft R: Shared care: samspil og konflikt mellem kommune,
praksislæge og sygehus: Aalborg kommunes demensudredningsmodel i praksis.
[in Danish: Shared care: coordination and conflict between municipality, GP
and hospital: The dementia diagnosing model of the municipality of Aalborg
in practice] 3. Aalborg: FLOS - Forskningscenter for Ledelse og Organisation
i Sygehusvæsenet; 2002.
37. Seemann J: Barriers between sectors in Health care. In The Challenge of
Chronic Diseases: can we do better?. Edited by: Jørgensen S, Hendriksen C,
Falkesgaard N. København: Klinisk Enhed for Sygdomsforebyggelse;
2003:37-42.
38. Seemann J: Løses sammenhængsproblemer med strukturdesign: hvad
med kulturen? [in Danish: Are problems with coordination solved by
structure design: what about the culture?]. FLOSNyt 2004, Maj:8-10.
39. Frolich A, Host D, Schnor H, Norgaard A, Ravn-Jensen C, Borg E, et al:
Integration of healthcare rehabilitation in chronic conditions. Int J Integr
Care 2010, 10:e033.
40. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS: Population trends
in the incidence and outcomes of acute myocardial infarction. N Engl J
Med 2010, 362:2155-2165.
41. Schiotz ML, Søgaard J, Vallgarda S, Krasnik A: Internationale
sammenligninger af sundhedssystemer [International comparisons of
health systems]. Ugeskr Laeger 2010, 172:771-774.
42. Latour B, Woolgar S: Laboratory life: social construction of scientific facts
Beverly Hills: Sage Publications; 1979.
43. Robinson R: The managment of chonic diseases. Health Policy Monitor
2004, 04.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6963/11/347/prepub
doi:10.1186/1472-6963-11-347
Cite this article as: Schiøtz et al.: Something is amiss in Denmark: A
comparison of preventable hospitalisations and readmissions for
chronic medical conditions in the Danish Healthcare system and Kaiser
Permanente. BMC Health Services Research 2011 11:347.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Schiøtz et al. BMC Health Services Research 2011, 11:347
http://www.biomedcentral.com/1472-6963/11/347
Page 10 of 10